AVXL

Anavex Life Sciences Corp

NASDAQ: AVXL · HEALTHCARE · BIOTECHNOLOGY

$3.06

-8.87% today

Updated 2026-06-05

Market cap

$245.12M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.46

Dividend yield

—

52W range

$3 – $14

Volume

1.2M

Market cap

$245.12M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.46

Dividend yield

—

52W range

$3 – $14

Volume

1.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$20.00

+553.59%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-7.15M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-47.98M	$-47.49M	$-43.00M	$-46.38M	$-5.68M
EPS	—	—	—	—	$-0.46
Free cash flow	$-24.24M	$-27.79M	$-30.81M	$-39.04M	$-7.15M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-01-06	MISSLING, CHRISTOPHER U	Buy	125,000	—
2026-01-06	BOENISCH, SANDRA	Buy	12,500	—
2025-10-02	MISSLING, CHRISTOPHER U	Buy	125,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AVXL	$245.12M	24	4.3	3.0	5.0	6.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Anavex Life Sciences Corp trades at $3.06. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Anavex Life Sciences Corp's stock price?

Anavex Life Sciences Corp (AVXL) trades at $3.06.

Is Anavex Life Sciences Corp overvalued?

Anavex Life Sciences Corp carries a Smart Value Score of 24/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Anavex Life Sciences Corp (AVXL)?

The 12-month analyst consensus target is $20.00, about 553.6% above the current $3.06. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-31.55%

Beta1.25

50D MA$3.15

200D MA$5.43

Shares out0.09B

Float0.09B

Short ratio—

Avg volume1.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AVXL vs LLY →AVXL vs JNJ →AVXL vs ABBV →Stock screener →